Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Reg DR until

NAV on July 31, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets 1,455 cr
Turnover Ratio 11.18%
Expense Ratio 1.81%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: Positive return: 4.24%
  • 1Y: Positive return: 7.82%
  • 3M: Positive return: 12.10%
  • 3Y: Positive return: 19.36%
  • 6M: Positive return: 17.94%
  • 5Y: Positive return: 13.68%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since almost 2 years)
ISIN INF277K018A5
Fund Family Tata
P/E Ratio 40.60
P/B Ratio 6.38
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR

Asset Allocation

  • Equity: 97.5%
  • Debt: 2.5%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -1.81
Beta 0.99
R-Squared 93.57
Info Ratio -0.59
Tracking Err 4.14
Sortino 1.293
Sharpe 0.788
Std Dev 16.352
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 4.28%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 94.46%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.26%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet

-

Best Sector Healthcare Funds

Name Latest NAV Returns 1y   Fund Assets Expense Ratio Risk
593.942 17.46% 4,998 cr 1.03% -
51.537 16.16% 3,253 cr 0.44% -
380.962 13.83% 1,308 cr 1.31% -
47.410 7.17% 6,625 cr 0.86% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata